Drotrecogin-alfa relatively cost effective in severe sepsis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1358, 2002-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drotrecogin-alfa warranted to tackle severe sepsis burden in Europe

By  

Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Drotrecogin-alfa warranted to tackle severe sepsis burden in Europe

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 391, 2002-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Drotrecogin alfa improves organ function in severe sepsis

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Drotrecogin Alfa (Activated): A Pharmacoeconomic Review of its Use in Severe Sepsis

By Frampton J.E.   Foster R.H.  

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 445-476

Adis International

Access to resources Recommend Favorite

Should patients with severe sepsis receive drotrecogin alfa?

By  

Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite